OUR PRESS RELEASES & COMPANY STATEMENTS
These press releases and company statements are intended for journalists and analysts/investors
Showing results for
These press releases and company statements are intended for journalists and analysts/investors
-
COVID-19 Guidance to Investigators
27 Mar 2020 -
Our Response to COVID-19
16 Mar 2020
Media contacts
For US-specific media inquiries, email: todd.a.siesky@viivhealthcare.com OR call +1 984 390 0345
For our global corporate press office, call +44 7557 290 420